Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
11.42
-0.20 (-1.72%)
Nov 13, 2026, 3:00 PM CST

SHA:603079 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
523.8457.67315.62323.72320.72514.75
Short-Term Investments
-10.5830-1020.07
Trading Asset Securities
65.01182.060.013.01-0.01
Cash & Short-Term Investments
588.82650.31345.63326.74330.72534.83
Cash Growth
1.03%88.15%5.78%-1.20%-38.16%-6.40%
Accounts Receivable
159.63159.06141.24119.26135.9133.38
Other Receivables
19.010.370.550.60.850.17
Receivables
178.64159.43141.79119.86136.75133.55
Inventory
237.68189.74197.54228.48292.06222.09
Other Current Assets
58.0410.9323.8120.0720.8328.35
Total Current Assets
1,0631,010708.77695.15780.36918.81
Property, Plant & Equipment
985.02894.67769.47674.77561.81579.96
Long-Term Investments
10.741.8621.0160.760.720.74
Goodwill
10.9110.9110.9110.9110.9110.91
Other Intangible Assets
199.53222.94225.58231.82218.2156.09
Long-Term Deferred Tax Assets
5.077.010.060.895.363.38
Long-Term Deferred Charges
1.211.956.168.674.236.87
Other Long-Term Assets
3.248.843.3536.2813.6468.06
Total Assets
2,2792,1991,7851,7191,6551,765

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
221.77143.16155.44129.61164151.33
Accrued Expenses
22.4445.8638.3133.8437.5736.03
Short-Term Debt
-0.7930.8294.7541.76167.39
Current Portion of Long-Term Debt
9.0860.110.14--
Current Portion of Leases
-0.320.80.30.590.59
Current Income Taxes Payable
14.724.653.382.985.043.21
Current Unearned Revenue
5.294.493.82.928.76.54
Other Current Liabilities
18.9541.4218.7130.937.8147.4
Total Current Liabilities
292.26246.7251.38295.45295.46412.5
Long-Term Debt
347.28317.75231144--
Long-Term Leases
0.44-0.49-0.30.87
Long-Term Unearned Revenue
7.826.786.655.467.586.95
Long-Term Deferred Tax Liabilities
3.474.433.714.288.437.53
Other Long-Term Liabilities
8.18.18.1---
Total Liabilities
659.37583.75501.34449.2311.78427.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
189.03189.03171.19171.19171.19171.19
Additional Paid-In Capital
913.3911.96669.19669.19669.19669.19
Retained Earnings
511.06504.68442.53423.26487.6480.09
Treasury Stock
-31.13-21.13-22.08-8.97--
Comprehensive Income & Other
0.12-----
Total Common Equity
1,5821,5851,2611,2551,3281,320
Minority Interest
37.130.2523.1415.3115.4516.49
Shareholders' Equity
1,6191,6151,2841,2701,3431,337
Total Liabilities & Equity
2,2792,1991,7851,7191,6551,765

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
356.8324.86263.23239.242.65168.85
Net Cash (Debt)
232.02325.4582.487.54288.07365.98
Net Cash Growth
-16.19%294.95%-5.86%-69.61%-21.29%-18.70%
Net Cash Per Share
1.231.830.480.521.652.13
Filing Date Shares Outstanding
206.44187.44169.32169.32171.19171.19
Total Common Shares Outstanding
206.44187.44169.32170.46171.19171.19
Working Capital
770.91763.71457.38399.69484.9506.32
Book Value Per Share
7.678.457.457.367.767.71
Tangible Book Value
1,3721,3511,0241,0121,0991,153
Tangible Book Value Per Share
6.657.216.055.946.426.74
Buildings
-304.63290.21279.73274.11272.42
Machinery
-666.22589.14528.41515.04479.2
Construction In Progress
-432.84335.96247.3293.3388.76